InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the complete record of transactions filed by YVER ANTOINE, Directeur Médical. Director active across 1 companies, notably Centessa Pharmaceuticals plc. In total, 4 disclosures have been logged. Total volume traded: €145k. The latest transaction was disclosed on 17 June 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€40,8049,200 shares@ €4.43530.0007% mcap28.2% of flow
Ordinary Shares
SEC:0000899243-22-023485:0·
€103,93720,222 shares@ €5.13980.0017% mcap71.8% of flow
Ordinary Shares
SEC:0000899243-22-018913:0·
0833,897 shares0
Ordinary Shares
SEC:0000899243-21-021436·
0833,897 shares0
Ordinary Shares
SEC:0000899243-21-021436:0·
4 of 4 declarations
About YVER ANTOINE
Antoine Yver is the Chief Medical Officer and EVP & Chairman of Development at Centessa Pharmaceuticals plc. In this role, he is responsible for the company's medical strategy and product development. Centessa Pharmaceuticals is an innovation-driven biopharmaceutical company. Antoine Yver brings valuable medical and scientific expertise to guide research and development initiatives.
